Isolation and characterization of exopolysaccharide with immunomodulatory activity from fermentation broth of Morchella conica
© Su et al; licensee BioMed Central Ltd. 2013
Received: 18 December 2012
Accepted: 18 December 2012
Published: 5 January 2013
Background and the purpose of this study
Mushroom polysaccharides have traditionally been used for the prevention and treatment of a multitude of disorders like infectious illnesses, cancers and various autoimmune diseases. In vitro and in vivo studies suggest that certain polysaccharides affect immune system function. Morchella conica (M. conica) is a species of rare edible mushroom whose multiple medicinal functions have been proven. Thus, the objective of this study is to isolate and characterize of exopolysaccharide from submerged mycelial culture of M. conica, and to evaluate its immunomodulatory activity.
A water-soluble Morchella conica Polysaccharides (MCP) were extracted and isolated from the fermentation broth of M. conica through a combination of DEAE-cellulose and Sephacryl S-300 HR chromatograph. NMR and IR spectroscopy has played a developing role in identification of polysaccharide with different structure and composition from fungal and plant sources, as well as complex glycosaminoglycans of animal origin. Thus, NMR and IR spectroscopy were used to analyze the chemical structure and composition of the isolated polysaccharide. Moreover, the polysaccharide was tested for its immunomodulatory activity at different concentrations using in vitro model.
The results showed that MCP may significantly modulate nitric oxide production in macrophages, and promote splenocytes proliferation. Analysis from HPLC, infrared spectra and nuclear magnetic resonance spectroscopy showed that MCP was a homogeneous mannan with an average molecular weight of approximately 81.2 kDa. The glycosidic bond links is →6)-α-D-Man p-(1→.
The results suggested that the extracted MCP may modulate nitric oxide production in macrophages and promote splenocytes proliferation, and it may act as a potent immunomodulatory agent.
KeywordsMorchella conica Exopolysaccharides Submerged liquid culture Immunomodulatory activity
Medicinal mushrooms have become an attractive option for functional food or as a source for the development of pharmaceuticals and nutraceuticals. The medicinal properties are due to various cellular components and secondary metabolites, which have been isolated and identified from the fruiting-body, cultured mycelium and cultured broth of mushrooms . Exopolysaccharides (EPS) are referred to secondary metabolite of microorganisms during the growth process, and secreted into the extracellular broth. Recently, many polysaccharides have been isolated from mushrooms . They have emerged as an important class of bioactive natural products in the biochemical and medical areas due to their specific biological activities such as hepatoprotective, antioxidant activity, immunomodulatory property, inhibition early stages of biofouling and gastroprotective effects . The documented immune-active polysaccharides, isolated from Opuntia polyacantha, Bupleurum smithii, and Sipunculus nudus, exhibited innate immunomodulatory activities through enhancing phagocytosis of macrophages, increasing production of NO and secretion of cytokine [4–6]. Previous reports have demonstrated that EPS from longan pulp, and Enteromorpha prolifera may not only modulate macrophages activities, but also enhance the spleen lymphocyte proliferation and cytokine production [7, 8]. These suggested that EPS represent a potential therapeutics with immunomodulatory action for their low toxicity and high potency.
Morchella conica, is an edible mushroom belonging to genus Morchella. It was used in Traditional Chinese Medicine to treat indigestion, excessive phlegm and shortness of breath. It has also been consumed as tasted food, health nutritional supplement for its high gastronomic quality, fatigue resistance and gastroprotective effects [9, 10]. However, wild Morchella conica is difficult to culture, and its price is expensive price . The fermentation broth of M. conica contains similar bioactive compounds and is rich in quantity compared with fermentation broth of M. conica and wild M. conica. Thus, bioactive compounds are obtained from fermentation broth of M. conica, and may serve as an ideal substitute for the wild M. conica, thereby resolving the problem of its limited production from wilds. To the best of our knowledge, there is no available report yet on the exopolysaccharides from fermentation broth of Morchella conica. In the present study, an immunomodulatory activity exopolysaccharide was isolated from submerged fermentation broth of Morchella conica. Beside, chemical structure of the isolated polysaccharide was also elucidated.
Material and method
Chemicals and materials
The strain of Morchella conica (labeled, No. 20110802) was obtained from the Sichuan Agricultural Academy of Sciences, Chengdu, China. DEAE-cellulose 52 and Sephacryl HR-300 were purchased from GE Healthcare Life Sciences (Uppsala, Sweden). Dextran T-2000, T-500, T-200 and T-70 were purchased from Pharmacia Co., Ltd. (Uppsala, Sweden). RAW264.7 cells were obtained from American Type Culture Collection (Manassass, VA, USA). Kunming mice (18~20 g) were obtained from the Animal Facility of the Institute of Chinese Traditional Medicine, Sichuan, China. The protocols of feeding were formed in accordance with the Guidelines of Institute of Chinese Traditional Medicine Animals Research Committee. All other reagents used were of analytical grade.
Extraction and isolation of exopolysaccharide
M. conica was cultured on synthetic potato dextrose agar (PDA) plates in a Petri dish at 25°C for 7 d. Then the seeds were grown in 250 ml Erlenmeyer flasks containing 100 ml liquid culture medium under agitation at 150 rev min-1 for 7 days at 25°C. 10% (v/v) of the seed culture was transferred into 20 L culture media (pH 6.4) on a rotary shaker incubator under agitation at 50 rev min-1 for 5 d at 28°C. The liquid culture medium used in this study is composed of 3 g/l glucose, 7 g/l sucrose, 3 g/l yeast extract, 5 g/l peptone, 0.1 g/l K2HPO4, 0.5 g/l KH2PO4, and 0.5 g/l MgSO4. The fermentation broth was harvested and centrifuged at 3000 rpm for 20 min from the culture. After centrifuging, the supernatant was treated by the Sevag method to remove protein and lipid, etc. . In brief, a mixed solution of chloroform: butanol = 4:1 was added in amount of 10% to the supernatant, which was stirred for 12 h. Then, this solution was subjected to centrifugal separation for 20 min at 10000 rpm to remove precipitation, and the supernatant was collected for next study. Next, after adding four-fold volume of 95% ethanol to this supernatant, the crude polysaccharide was obtained through precipitation. This agglutinant was filtered off to remove ethanol, and dialyzed for 12 h (MWCO 5000, Sigma) and lyophilized using Thermo Savant MODULYO freeze-dryer (EC Apparatus Corp., Holbrook, NY, USA) for further study. The sample was re-dissolved in 20 mM Tris–HCl (pH 8.0) and applied to DEAE-Cellulose 52 anion-exchange chromatography column (2.6 × 50 cm, Whatmann) equilibrated with 20 mM Tris–HCl (pH 8.0), and eluted with a linear gradient of NaCl from 0 mM to 500 mM in 20 mM Tris–HCl (pH 8.0) at a flow rate of 2 mL/min. The eluted samples were monitored by the phenol-sulfuric acid method , and the four yielded fractions were collected and combined. Subsequently, the samples were further subjected to Sephacryl S-300HR column (2.6 × 100 cm, Pharmacia Co.) and eluted with 10 mM NaCl at a flow rate of 1 mL/min. Fractions containing EPS were pooled and dialyzed. Then, the sample was subjected to lyophilized, and used directly for analysis or stored at -20°C for further study.
Innate and adaptive immunomodulatory activity of MCP
Measurement of NO production
RAW264.7 cells were plated in 24-well culture plates in RPMI 1640 at a density of 1 × 106 for 2 h. LPS (10 μg/ml), and different concentrations MCP (0, 50, 100, 200, 300, 400 and 500 μg/ml) were added, and the mixture was incubated for 48 h. Production of nitric oxide (NO) was measured according to the Griess method . Briefly, supernatants were mixed with an equal volume of Griess reagent, which was prepared by mixing one part of 0.1% (w/v) N-(1-naphthyl) ethylenediamine with one part of 1% (w/v) sulfanilamide in 5% phosphoric acid. After 20 min, absorbance was measured at 540 nm using a UV/vis spectrophotometer (TU-1901, Purkinje General, Beijing, China). The nitrite concentration was calculated using sodium nitrite as a standard.
Lymphocyte proliferation test in vitro
Spleen lymphocytes were prepared as reported previously with some modifications . Briefly, mice were killed by cervical dislocation, and obtained spleen sterile. Medium containing spleen lymphocytes was collected, and added equal volume 0.83% Tris-NH4Cl for lysis the red blood cells for 5 min. The suspended cells were centrifuged at 1500 rpm for 15 min, and resuspended with complete RPMI-1640. The resuspended cells were subsequently seeded onto culture plates for 1 h at 37°C and 5% CO2 to remove the adherent cells. The non-adherent cells were designated as spleen lymphocytes. Cell viability was ≥95% in all experiments. The non-adherent cells, which were spleen lymphocytes, were plated in 96-well culture plates in RPMI 1640 at a density of 1 × 106. Different concentration MCP (0, 50, 100, 200, 300, 400 and 500 μg/ml) was added into 9-wells, and one of three wells added 5 μg/ml ConA, and the other three wells added 5 μg/ml LPS, the rest three wells was just MCP without ConA and LPS. The mixture was incubated for 72 h at 37°C and 5% CO2. The splenocytes proliferation was assessed by using MTT-based colorimetric assay.
Measurement of homogeneity and molecular weight of MCP
The homogeneity and average molecular weight of MCP were measured and determined by the high performance gel permeation chromatography (HPGPC)method on a Waters 1525 HPLC system (Waters, Boston, US) equipped with a TSK gel 5000 PWXL column (7.8 × 300 mm, Tosoh Co., Tokyo, Japan) and a Alltech 2000ES (Alltech Associates, Inc., USA) Evaporative Light Scatttering Detector (ELSD). The molecular weight was estimated by reference to the calibration curve made under the conditions described above from Dextran T-series standards (T70, T200, T500 and T2000) of known molecular weight.
Monosaccharide composition analysis of MCP
The polysaccharide, MCP (~2 mg), was hydrolysed with 2 M trifluoroacetic acid (TFA) for 10 h at 110°C in a sealed glass tube. When the residual acid was removed using methyl alcohol, and the hydrolysate was analyzed by HPLC/ELSD system. The chromatograph was fitted with an Alltech Prevail carbohydrate column (Alltech Associates, Inc., USA). Results were compared with the following monosaccharide standards: D-glucose, L-rhamnose, D-xylose, D-galactose, D-mannose and L-arabinose.
Analysis of Infrared (IR) spectra and Nuclear magnetic resonance (NMR)
IR spectroscopy, and 1H and 13C NMR were used to analyze the structural features of MCP. IR spectrum of MCP were recorded on a Fourier transform infrared spectroscopy (Nicolet 170 SX, FTIR, US), and the test specimens of polysaccharide film were prepared by KBr-disk method. The 1H and 13C NMR measurements were carried out at 600 and 150 Hz, respectively, on a Bruke 600 Hz NMR instrument (Bruker Avance, Karlsruhe, Germany). All chemical shifts were in relative to Me4Si.
Data were expressed as means ± SD. The significance of difference was evaluated with one-way ANOVA, followed by Student’s t-test to statistically identify differences between the control and treated groups. Significant differences were set at P < 0.05 and P < 0.01.
Results and discussion
Isolation and purification of polysaccharide
Purification and production yields of Morchella conica polysaccharide
Total Polysaccharide (mg)
Molecular weight and monosaccharide composition
Molecular weight has been recognized as a critical parameter in the antigenicity of polysaccharides. Most polysaccharides with medicinal properties are high molecules above 100 kDa of molecular weight. Moreover, some polysaccharides have low molecular weights, such as polysaccharide from Ganoderma lucidum (8 kDa, 22 kDa), Euphorbia fischeriana (49.5 kDa) and Armillariella tabescens (49.5 kDa), etc., which were found to exhibit bioactivity [14, 16, 17]. The molecular weight of purified MCP was about 81.2 kDa by HPLC analysis using dextrans as standards, which was in the range reported for other mushroom polysaccharides. According to HPLC equipped with a Alltech Prevail carbohydrate column and ELSD analyzing, it was found that MCP was composed of only one monosaccharide, D-mannose (data not shown).
Structure elucidation of MCP
Measurement of NO production in vitro
After RAW264.7 cells were incubated with different concentrations of polysaccharides (0, 50, 100, 200, 300, 400 and 500 μg/ml) or LPS (10 μg/ml) for 24 h, NO concentrations in culture supernatants were assessed by NO2- contents in the Griess reaction. As shown in Figure 3, 10 μg/ml LPS could significantly increase production of NO (p<0.01), and MCP may significantly induce the production of NO with a dose-dependent manner at 50-200 μg/ml. However, the stimulate roles showed decrease treads when the concentrations of EPS concentrations are higher than 200 μg/ml. Earlier studies showed that the mannose receptor (MR) was existed on the cell surface of macrophage, and involved in the process of production reactive oxidants, phagocytosis, and endocytosis . The polysaccharides with mannose, trehalose and N-acetyl glucosamine residues may bind to MR, and then the complex may active macrophage via NF-κB pathway or other signaling pathways, which will enhance the secretion of cytokines, such as IL-1β, IL-6, and GM-CSF, etc. [22, 23]. Thus, they play critical role in cell-mediated immunity and humoral immunity. In the present study, results showed that MCP may induce the production of NO, and modulate the innate immune response at the specific concentration ranges.
Lymphocyte proliferation in vitro
Culture of M. conica fruiting bodies usually takes at least three months; therefore compared with the extraction of polysaccharides from the fruiting bodies of M. conica, the production and purification of polysaccharides from fermentation broth can significantly shorten the culture period and provide a faster way of polysaccharide production. In the present study, we showed, for the first time that the polysaccharides isolated and characterized from fermentation broth of M. conica. In addition, it is important to note that MCP has immunomodulatory activity, and may be seen as a promising immunopotentiating agent in health-care food or the treatment of infectious diseases. Further in-depth study will focus on between the mechanism of immunomodulatory activity and structure-function relationship.
This work was supported by Fungus medicine research and development of Sichuan Provincial Science and Technology Innovation Team, Sichuan mushroom innovative team deep processing of post construction project (Chuan  No. 75), Resource collection and breeding of medicinal fungi, and Sichuan Province Key Scientific and Technological Projects.
- Wasser SP: Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol. 2011, 89: 1323-1332. 10.1007/s00253-010-3067-4.View ArticlePubMed
- Stachowiak B, Reguła J: Health-promoting potential of edible macromycetes under special consideration of polysaccharides: a review. Eur Food Res Technol. 2012, 234: 369-380. 10.1007/s00217-011-1656-9.View Article
- Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME: The immunobiology of mushrooms. Exp Biol Med. 2008, 233: 259-276. 10.3181/0708-MR-227.View Article
- Schepetkin IA, Xie G, Kirpotina LN, Klein RA, Jutila MA, Quinn MT: Macrophage immunomodulatory activity of polysaccharides isolated from Opuntia polyacantha. Int Immunopharmacol. 2008, 8: 1455-1466. 10.1016/j.intimp.2008.06.003.PubMed CentralView ArticlePubMed
- Cheng XQ, Li H, Yue XL, Xie JY, Zhang YY, Di HY, Chen DF: Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifolium. Ethnopharmacol. 2010, 130: 363-368. 10.1016/j.jep.2010.05.019.View Article
- Zhang CX, Dai ZR: Immunomodulatory activities on macrophage of a polysaccharide from Sipunculus nudus L. Food Chem Toxicol. 2011, 49: 2961-2967. 10.1016/j.fct.2011.07.044.View ArticlePubMed
- Kuang H, Xia Y, Yang B, Wang Q, Wang Y: Screening and comparison of the immunosuppressive activities of polysaccharides from the stems of Ephedra sinica Stapf. Carbohydr Polymers. 2011, 83: 787-795. 10.1016/j.carbpol.2010.08.056.View Article
- Kim JK, Cho ML, Karnjanapratum S, Shin IS, You SG: In vitro and in vivo immunomodulatory activity of sulfated polysaccharides from Enteromorpha prolifera. Int J Biol Macromol. 2011, 49: 1051-1058. 10.1016/j.ijbiomac.2011.08.032.View ArticlePubMed
- Gursoy N, Sarikurkcu C, Cengiz M, Solak MH: Antioxidant activities, metal contents, total phenolics and flavonoids of seven Morchella species. Food Chem Toxicol. 2009, 47: 2381-2388. 10.1016/j.fct.2009.06.032.View ArticlePubMed
- Ismet O, Serkan S, Ugur S, Lutfiye E, Osman S: Bioactivity and mineral contents of wild-grown edible Morchella conica in the Mediterranean Region. J Consumer Protection Food Safety. 2010, 5: 453-457.
- Turkoglu A, Kivrak I, Mercan N, Duru ME, Gezer K, Turkoglu H: Antioxidant and antimicrobial activities of Morchella conica Pers. Afr J Biotechnol. 2006, 5: 1146-1150.
- Alum N, Gupta PC: Structure of a water-soluble polysaccharide from the seeds of Cassia angustifolia. Planta Med. 1986, 50: 308-310.View Article
- Masuko T, Minami A, Iwasaki N, Majima T, Nishimura S, Lee YC: Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. Anal Biochem. 2005, 339: 69-72. 10.1016/j.ab.2004.12.001.View ArticlePubMed
- Schepetkin IA, Faulkner CL, Nelson-Overton LK, Wiley JA, Quinn MT: Macrophage immunomodulatory activity of polysaccharides isolated from Juniperus scopolorum. Int Immunopharmacol. 2005, 5: 1783-1799. 10.1016/j.intimp.2005.05.009.View ArticlePubMed
- Luo X, Xu XY, Yu MY, Yang ZR, Zheng LY: Characterisation and immunostimulatory activity of an [alpha]-(1–>6)-d-glucan from the cultured Armillariella tabescens mycelia. Food Chem. 2008, 111: 357-363. 10.1016/j.foodchem.2008.03.076.View ArticlePubMed
- Liu J, Sun Y, Yu C, Liu L: Chemical structure of one low molecular weight and water-soluble polysaccharide (EFP-W1) from the roots of Euphorbia fischeriana. Food Chem. 2012, 87: 1236-1240.
- Joseph S, Sabulal B, George V, Antony KR, Janardhanan KK: Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta Pharm. 2011, 61: 335-342.View ArticlePubMed
- Jung YS, Yang BK, Jeong YT, Islam R, Kim SM, Song CH: Immunomodulating activities of water-soluble exopolysaccharides obtained from submerged culture of Lentinus lepideus. J Microbiol Biotechnol. 2008, 18: 1431-1438.PubMed
- Wang ZM, Peng X, Daniel Lee KL, Cheuk-on TJ, Chi-Keung Cheung P, Wu JY: Structural characterisation and immunomodulatory property of an acidic polysaccharide from mycelial culture of Cordyceps sinensis fungus Cs-HK1. Food Chem. 2011, 125: 637-643. 10.1016/j.foodchem.2010.09.052.View Article
- Zhao GH, Kan JQ, Li ZX, Chen ZD: Structural features and immunological activity of a polysaccharide from Dioscorea opposita Thunb roots. Carbohydr Polymers. 2005, 61: 125-131. 10.1016/j.carbpol.2005.04.020.View Article
- Schepetkin IA, Quinn MT: Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int Immunopharmacol. 2006, 6: 317-333. 10.1016/j.intimp.2005.10.005.View ArticlePubMed
- Jiang Z, Hama Y, Yamaguchi K, Oda T: Inhibitory effect of sulphated polysaccharide porphyran on nitric oxide production in lipopolysaccharide-stimulated RAW264.7 macrophages. J Biochem. 2012, 151: 65-74. 10.1093/jb/mvr115.View ArticlePubMed
- Monick MM, Hunninghake GW: Activation of second messenger pathways in alveolar macrophages by endotoxin. Eur Respir J. 2002, 20: 210-222. 10.1183/09031936.02.00252001.View ArticlePubMed
- Lai CY, Hung JT, Lin HH, Yu AL, Chen SH, Tsai YC, Shao LE, Yang WB, Yu J: Immunomodulatory and adjuvant activities of a polysaccharide extract of Ganoderma lucidum in vivo and in vitro. Vaccine. 2010, 28: 4945-4954. 10.1016/j.vaccine.2010.05.037.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.